Arrowhead Pharmaceuticals, Inc. (ARWR)
NASDAQ: ARWR · Real-Time Price · USD
66.67
-2.95 (-4.24%)
Dec 30, 2025, 11:26 AM EST - Market open
Arrowhead Pharmaceuticals Stock Forecast
Stock Price Forecast
The 10 analysts that cover Arrowhead Pharmaceuticals stock have a consensus rating of "Strong Buy" and an average price target of $63.7, which forecasts a -4.45% decrease in the stock price over the next year. The lowest target is $17 and the highest is $100.
Price Target: $63.7 (-4.45%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Arrowhead Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 4 | 4 | 4 | 5 |
| Buy | 4 | 3 | 3 | 2 | 2 | 2 |
| Hold | 3 | 2 | 2 | 2 | 4 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 8 | 9 | 8 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $70 → $100 | Buy | Maintains | $70 → $100 | +49.99% | Dec 17, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $52 → $80 | Buy | Maintains | $52 → $80 | +19.99% | Dec 11, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $62 → $81 | Strong Buy | Maintains | $62 → $81 | +21.49% | Dec 9, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $80 → $85 | Strong Buy | Maintains | $80 → $85 | +27.49% | Dec 2, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $42 → $62 | Strong Buy | Maintains | $42 → $62 | -7.00% | Dec 1, 2025 |
Financial Forecast
Revenue This Year
424.89M
from 829.45M
Decreased by -48.77%
Revenue Next Year
287.96M
from 424.89M
Decreased by -32.23%
EPS This Year
-3.29
from -0.01
EPS Next Year
-4.48
from -3.29
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 629.5M | 462.1M | |||
| Avg | 424.9M | 288.0M | |||
| Low | 98.0M | 135.9M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -24.1% | 8.8% | |||
| Avg | -48.8% | -32.2% | |||
| Low | -88.2% | -68.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -1.77 | -2.73 | |||
| Avg | -3.29 | -4.48 | |||
| Low | -5.81 | -6.08 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.